Howard Hughes Medical Institute’s Johnson Controls International JCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-132
Closed -$15.8K – 272
2025
Q4
$15.8K Sell
132
-9
-6% -$1.03K 0.01% 144
2025
Q3
$15.5K Sell
141
-1
-0.7% -$107 0.01% 145
2025
Q2
$15K Buy
+142
New +$13.1K 0.01% 146
2017
Q1
– Sell
-7,432
Closed -$306K – 158
2016
Q4
$306K Buy
7,432
+2,385
+47% +$104K 0.07% 112
2016
Q3
$235K Buy
+5,047
New +$234K 0.06% 119

Other funds holding JCI

Howard Hughes Medical Institute's JCI Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Johnson Controls International (JCI) in Q1 2026, closing a stake of 132 shares — an estimated $15.8K sold.

Howard Hughes Medical Institute first reported a position in JCI in Q3 2016 and held it in 5 quarters. The position peaked at $306K in Q4 2016. 1,568 funds tracked by Wall St. Rank hold JCI as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Johnson Controls International position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 132 Johnson Controls International shares in Q1 2026, an estimated $15.8K.
  • Howard Hughes Medical Institute first reported a position in Johnson Controls International in Q3 2016 and held it in 5 quarters.
  • Howard Hughes Medical Institute's Johnson Controls International position peaked at $306K in Q4 2016.
  • 1,568 funds tracked by Wall St. Rank held Johnson Controls International as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.